Trials / Active Not Recruiting
Active Not RecruitingNCT06501001
Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)
Time Restricted Eating and High-Intensity Interval Training to Improve Health in Patients With Metabolic Syndrome
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- University of Castilla-La Mancha · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Studies in mice provide compelling evidence that feeding/fasting cycles can be altered to produce beneficial effects on weight loss and cardiometabolic health markers in the absence of caloric restriction. Limited research in subjects with metabolic syndrome (MetS) suggests that this feeding paradigm may also apply to human health when combined with an exercise training program, but more research is needed to confirm this hypothesis. This project will determine the independent and combined effects of high-intensity interval training and time-restricted eating on cardiometabolic factors among overweight or obese patients with MetS. The intervention period will be sixteen weeks. Before and after the intervention, MetS components (i.e., MetS Z score), body composition, and physical fitness will be measured and compared between groups who are doing either high-intensity interval training, time-restricted eating, both high-intensity interval training and time-restricted eating, or who are in a control group. Physical activity, diet, sleep quality, and intervention adherence will also be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | High-Intensity Interval Training | Three weekly, supervised exercise sessions with high intensity. Each session will last for 45 minutes. The intervention period will be sixteen weeks. |
| BEHAVIORAL | Experimental: Time-Restricted Eating | Restricted daily window of caloric intake to a maximum 10 hours. The intervention period will be sixteen weeks. |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2024-07-15
- Last updated
- 2025-12-02
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06501001. Inclusion in this directory is not an endorsement.